breast neoplasms

Showing NaN - NaN of 46

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Tumors, Breast Cancer Trial in Busan, Seoul (Breast MRI for Breast Cancer Detection)

Not yet recruiting
  • Breast Neoplasms
  • Breast Cancer
  • Breast MRI for Breast Cancer Detection
  • Busan, BusanJin-Gu, Korea, Republic of
  • +3 more
Apr 2, 2023

Breast Tumors Trial in Worldwide (Abemaciclib, Standard Adjuvant ET, Placebo)

Active, not recruiting
  • Breast Neoplasms
  • Daphne, Alabama
  • +176 more
Jan 18, 2023

Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,

Recruiting
  • Breast Neoplasms
  • +2 more
  • Trastuzumab Deruxtecan
  • +5 more
  • Springdale, Arkansas
  • +203 more
Jan 13, 2023

Breast Tumors Trial in Israel, Korea, Republic of, United States (Atezolizumab (MPDL3280A), an engineered anti-programmed

Active, not recruiting
  • Breast Neoplasms
  • Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody
  • +7 more
  • Birmingham, Alabama
  • +26 more
Dec 21, 2022

Breast Tumors Trial in Worldwide (PD-0332991, Letrozole, Placebo)

Active, not recruiting
  • Breast Neoplasms
  • Bellflower, California
  • +304 more
Dec 6, 2022

Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)

Active, not recruiting
  • Breast Neoplasms
  • Fayetteville, Arkansas
  • +141 more
Nov 15, 2022

Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane)

Completed
  • Breast Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Yuma, Arizona
  • +93 more
Nov 4, 2022

Breast Tumors Trial in Worldwide (Imlunestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Neoplasms
  • Jonesboro, Arkansas
  • +330 more
Aug 23, 2022

Breast Tumors, Tumor Metastasis Trial in Worldwide (Imlunestrant, Exemestane, Fulvestrant)

Recruiting
  • Breast Neoplasms
  • Neoplasm Metastasis
  • Chandler, Arizona
  • +238 more
Aug 17, 2022

Breast Tumors Trial in Worldwide (pembrolizumab, paclitaxel, nab-paclitaxel)

Recruiting
  • Breast Neoplasms
  • pembrolizumab
  • +6 more
  • Tucson, Arizona
  • +188 more
Aug 11, 2022

Breast Tumors Trial in Worldwide (Palbociclib, Placebo, Tamoxifen)

Active, not recruiting
  • Breast Neoplasms
  • Nagoya, Aichi, Japan
  • +22 more
Apr 4, 2022

Breast Tumors Trial in Seoul (Olaparib, Durvalumab)

Active, not recruiting
  • Breast Neoplasms
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jun 18, 2021

MAstectomy With Reconstruction Including Robot Endoscopic

Recruiting
  • Breast Neoplasms
  • +4 more
  • Robotic or endoscopic nipple sparing mastectomy
  • Conventional mastectomy (including nipple sparing mastectomy, skin sparing mastectomy)
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine
Jun 4, 2021

Breast Tumors Trial in Worldwide (Herceptin)

Completed
  • Breast Neoplasms
  • Tirana, Albania
  • +436 more
Apr 26, 2021

Breast Tumors Trial in Seoul (Internal mammary node irradiation, No internal mammary node irradiation)

Active, not recruiting
  • Breast Neoplasms
  • Internal mammary node irradiation
  • No internal mammary node irradiation
  • Seoul, Korea, Republic of
    Yonsei Severance Hospital
Mar 16, 2021

Breast Tumors Trial in Worldwide (Ipatasertib, Paclitaxel, Placebo)

Completed
  • Breast Neoplasms
  • Fullerton, California
  • +43 more
Feb 18, 2021

Breast Tumors Trial in Worldwide (Lapatinib, Letrozole, Placebo)

Completed
  • Breast Neoplasms
  • Tucson, Arizona
  • +277 more
Feb 8, 2021

Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Background hormonal therapy)

Terminated
  • Breast Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +2 more
  • Bakersfield, California
  • +70 more
Jul 29, 2020

Testing BRCA 1/2 Mutation Using Next Generation Sequencing

Completed
  • Breast Neoplasms
  • Breast Cancer
    • Seoul, Korea, Republic of
      Yonsei University College of Medicine
    Oct 3, 2019

    Biological Linkage Between Circadian Disruption and Cancer

    Completed
    • Breast Neoplasms
      • Seoul, Jongno-gu, Korea, Republic of
        Seoul National University Hospital
      Sep 22, 2019

      Hot Flashes, Breast Tumors Trial in Goyang, Seongnam, Seoul (Desvenlafaxine succinate 100mg, Desvenlafaxine succinate 50mg,

      Terminated
      • Hot Flashes
      • Breast Neoplasms
      • Desvenlafaxine succinate 100mg
      • +2 more
      • Goyang, Gyeonggi-do, Korea, Republic of
      • +2 more
      Sep 18, 2019

      Breast Tumors Trial in Worldwide (BIBW 2992, trastuzumab, vinorelbine)

      Completed
      • Breast Neoplasms
      • BIBW 2992
      • +2 more
      • Birmingham, Alabama
      • +206 more
      Jul 4, 2019

      Breast Tumors Trial in Worldwide (Carboplatin, Docetaxel, Pertuzumab)

      Completed
      • Breast Neoplasms
      • Fullerton, California
      • +78 more
      Jun 25, 2019